ArticleNature communications2026
Large language models decode narrative pathology reports to define clinically relevant subtypes in IgA nephropathy.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease worldwide, with a highly heterogeneous clinical course. Current biopsy-based risk assessment relies largely on structured histological scores, such as the Oxford MEST-C score, which summarize selected lesions but may omit information contained in routine narrative pathology reports. Here we show that large language model-based analysis of routine biopsy reports identifies reproducible pathological subtypes with prognostic relevance in IgAN. We studied 3,078 adults with primary IgAN from two hospitals in Wenzhou, China, using the First Affiliated Hospital cohort for subtype discovery and model development and the Second Affiliated Hospital cohort for independent external validation. Unsupervised clustering identified two subtypes, low-injury and high-injury, that differed in clinical presentation, histological severity and kidney outcomes. The high-injury subtype was independently associated with a higher risk of the composite kidney endpoint after adjustment for baseline clinical factors and the complete Oxford MEST-C score set (hazard ratio, 2.57; 95% confidence interval, 1.25-5.29). Interpretability analyses indicated that subtype separation was driven mainly by chronic tubulointerstitial injury and inflammatory burden. Exploratory analyses suggested heterogeneity in corticosteroid-associated outcome patterns across subtypes. These findings indicate that routine narrative biopsy reports contain prognostic information that complements structured pathological scoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.